{
    "clinical_study": {
        "@rank": "13411", 
        "arm_group": [
            {
                "arm_group_label": "DM1 subject with cardiopathy", 
                "arm_group_type": "Active Comparator", 
                "description": "Clinical examination, Skin biopsy, Blood and urine sampling"
            }, 
            {
                "arm_group_label": "DM1 subject without cardiopathy", 
                "arm_group_type": "Active Comparator", 
                "description": "Clinical examination, Skin biopsy, Blood and urine sampling"
            }, 
            {
                "arm_group_label": "Not DM1subject", 
                "arm_group_type": "Active Comparator", 
                "description": "Clinical examination, Skin biopsy, Blood and urine sampling"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the study is the modelisation of human cardiomyocyts from pluripotent stem\n      cells in order to study the cardiac alterations induced by CTG expansions."
        }, 
        "brief_title": "Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "DM1", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for DM1 patient with cardiomyopathy:\n\n          -  aged 20-50\n\n          -  DM1 confirmed by molecular analysis\n\n          -  Confirmed cardiomyopathy (infrahissiens conduction disorders)\n\n          -  able to sign the consent form\n\n          -  affiliated to european social security.\n\n        Inclusion Criteria for DM1 patient without cardiomyopathy\n\n          -  aged 20-50\n\n          -  DM1 confirmed by molecular analysis\n\n          -  No cardiomyopathy (no infrahissiens conduction disorders or other trouble linked to\n             DM1)\n\n          -  able to sign the consent form\n\n          -  affiliated to european social security.\n\n        Inclusion Criteria for controls\n\n          -  aged over 18\n\n          -  brother, sister, father or mother of the DM1 patient\n\n          -  No DM1 confirmed by molecular analysis (CTG repetition under 38)\n\n          -  No cardiac disorders.\n\n          -  able to sign the consent form\n\n          -  affiliated to european social security.\n\n        Exclusion Criteria:\n\n          -  no pragnant or nursing women\n\n          -  patient unable to understand informed consent\n\n          -  patient under juridic protection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02084407", 
            "org_study_id": "DM1-Fibroblasts"
        }, 
        "intervention": {
            "arm_group_label": [
                "DM1 subject with cardiopathy", 
                "DM1 subject without cardiopathy", 
                "Not DM1subject"
            ], 
            "intervention_name": "Clinical examination, skin biopsy, blood and urine sampling", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "DM1", 
            "Cardiopathy", 
            "Adult"
        ], 
        "lastchanged_date": "March 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75013"
                }, 
                "name": "Institute of Myology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients", 
        "overall_contact": {
            "email": "l.servais@institut-myologie.org", 
            "last_name": "Laurent Servais, MD PhD", 
            "phone": "+33142166647"
        }, 
        "overall_contact_backup": {
            "email": "karim.wahbi@psl.aphp.fr", 
            "last_name": "Karim Wahbi, MD PhD", 
            "phone": "+33142163775"
        }, 
        "overall_official": {
            "affiliation": "Institute of Myology", 
            "last_name": "Laurent Servais, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Measure of DM1 alterations in human cardiomyocytes derived from induced pluripotent stem cells", 
            "safety_issue": "No", 
            "time_frame": "At baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02084407"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Molecular changes in human DM1 cardiomyocytes expressing pathogenic CUGexp-RNA", 
            "safety_issue": "No", 
            "time_frame": "At baseline"
        }, 
        "source": "Institut de Myologie, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut de Myologie, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}